Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Myasthenia Gravis × Rituximab × Clear all

Phase

Status

Completed 4 Unknown 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 38 Lymphoma, B-Cell, Marginal Zone 22 Lymphoma, Mantle-Cell 20 Lymphoma, Follicular 17 Lymphoma 17 Lymphoma, Non-Hodgkin 14 Lymphoma, B-Cell 13 Leukemia, Lymphocytic, Chronic, B-Cell 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Burkitt Lymphoma 9 Recurrence 8 Waldenstrom Macroglobulinemia 7 Neoplasms 6 Leukemia, Hairy Cell 4 Leukemia, B-Cell 3 Leukemia 3 beta-Thalassemia 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasm, Residual 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Myeloid, Acute 2 Leukemia, Biphenotypic, Acute 2 Hodgkin Disease 2 Hematologic Neoplasms 2 Heart Failure 2 Epstein-Barr Virus Infections 2 Dendritic Cell Sarcoma, Interdigitating 2 Blastic Plasmacytoid Dendritic Cell Neoplasm 2 Anemia, Refractory, with Excess of Blasts 2 Thalassemia 1

Interventions

efgartigimod alfa 6 fludarabine 5 Cyclophosphamide 5 ravulizumab 4 zilucoplan 2 telitacicept 2 rozanolixizumab 2 Prednisone 2 remibrutinib 1 iptacopan 1 inebilizumab 1 bu-zhong-yi-qi-tang 1 Walk Test 1 Tacrolimus 1 Steroids 1 Rituximab 1 Pyridostigmine Bromide 1 Prednisolone 1 Mycophenolic Acid 1 Diagnostic Self Evaluation 1 Data Collection 1 Cognitive Behavioral Therapy 1 Cladribine 1 Biomarkers 1 Azathioprine 1 Alleles 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05868837 2025-08-01

REFINE

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase 3 Recruiting

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡